|1.||Kostin, Ia V: 2 articles (09/2003 - 05/2003)|
|2.||Blinov, D S: 2 articles (09/2003 - 05/2003)|
|3.||Moiseeva, I Ia: 2 articles (09/2003 - 05/2003)|
|4.||Shmyreva, M V: 1 article (11/2000)|
|5.||Klimovich, Y G: 1 article (11/2000)|
|6.||Sernov, L N: 1 article (11/2000)|
|7.||Kostin, Y V: 1 article (11/2000)|
|8.||Moiseeva, I Y: 1 article (11/2000)|
|9.||Kulikova, N N: 1 article (11/2000)|
|1.||Myocardial Ischemia (Ischemic Heart Diseases)
09/01/2003 - "For drugs administered in a single isotoxic dose, the therapeutic effect of quaternidine in animals with acute myocardial ischemia considerably exceeds the duration of action of lidocaine and trimecaine."
05/01/2003 - "The therapeutic effect of quaternidine in animals with acute myocardial ischemia lasts for about 8 h, which more than 20 times longer as compared to the duration of action of both lidocaine and trimecaine."
|2.||Cardiac Arrhythmias (Arrythmia)
11/01/2000 - "High antiarrhythmic activity of a new Russian antiarrhythmic drug quaternidine in ventricular arrhythmia was studied in 96 coronary patients by Holter monitoring, bicycle ergometry, and echocardiography. "
05/01/2003 - "The results of experiments on cats and dogs showed that quaternidine, a quaternary ammonium derivative of trimecaine, exceeds the structural precursors (trimecaine and lidocaine), as well as the reference drugs quinidine and propranolol, in intensity of the antiarrhythmic action upon single administration on the occlusive and reperfusive arrhythmia models. "
|3.||Quaternary Ammonium Compounds (Ammonium)